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We report on a 62-year-old male, who had resection of a large ductal carcinoma in the body and tail of the
pancreas. Four months later a metastasis was removed from the abdominal scar, and 14 months later another
metastasis was removed from the anterior wall ofthe stomach. Moreover, he had a left mastectomy followed
by radiation therapy for a primary ductal carcinoma and a transurethral resection of the prostate because of
benign hyperplasia. A minor focus ofprimary highly differentiated adenocarcinoma was found in the chips.
More than 6 years later, the patient is without any signs of recurrences.
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INTRODUCTION
Five-year survival after resection for ductal carcinoma in the body or tail of the
pancreas is extremely rare, and only four cases have been reported in the literature.
We report on a patient with proven ductal carcinoma of the pancreas, who is alive
more than six years after pancreatic resection.
CASE HISTORY
A 62-year-old male was admitted after halfa year of intermittent pain in the upper left
abdominal quadrant, malaise and rumbling ofthe bowels, but no weight loss. Physical
examination revealed no abdominal mass. Chest X-ray was normal. Liver chemistry,
hemoglobin, blood cell count, fatty acids, cholesterol, electrolytes and blood glucose
were within normal limits. The sedimentation rate was slightly raised, and serum
carcinoembryonic antigen was 16 micromol/1 (normal < 2.5 micromol/1).
Ultrasonography demonstrated a solid mass in the tail of the pancreas and fine-
needle biopsy showed malignant cells. Abdominal angiography showed a peripheral
occlusion of the splenic artery.
At laparotomy a tumor measuring 11 by 10 by 7 cm was found in the body and tail
of the pancreas. It compressed the splenic vessels and the middle colic artery. There
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were no liver metastases. Resection ofthe pancreatic body and tail, the transverse colon
and splenectomywas performed. Regional lymph nodes removed during the operation,
and one in the resected specimen were without metastases. In the resected lesser
omentum and retroperitoneal tissue two small areas contained carcinoma. The pos-
toperative course was uneventful.
Four months later a solitary metastasis was excised from the abdominal scar. Ten
months later the patient had upper abdominal pain, and ultrasonography showed a 6
cm tumor in the anterior wall of the stomach. At laparotomy the tumor was adherent
to the left colonic flexure, and resection of the stomach and colon were performed.
Three lymph nodes removed during operation and four in the specimen were without
metastases.
At twenty-one months a tumor occurred in the left breast, suspected to be a
metastasis from the pancreatic cancer, and a mastectomy was performed. At thirty-one
months left axillary lymph node dissection was performed because of metastases, and
histological revision of the specimen showed ductal breast carcinoma. One of three
lymph nodes contained carcinoma and radiation therapy was given. At thirty-nine
months, a transurethral resection of the prostate was performed for hyperplasia.
All histological slides were reviewed. The primary tumor in the pancreas was a poorly
differentiated ductal adenocarcinoma (Figure 1). There was no tumor invasion ofveins
or nerves and the resection lines were without cancer. The histology was also typical
for a primary pancreatic adenocarcinoma, that other primary pancreatic tumors
including endocrine and germinative tumors could be ruled out. The tumors in the
abdominal scar and stomach were compatible with metastases from the pancreatic
carcinoma. The breast tumor was a primary, poorly differentiated ductal breast
carcinoma, and in the chips from the prostate a minor focus of primary, highly
differentiated prostatic adeno-carcinoma was identified. Examination for estrogen
receptors was not performed and cannot be done now on the formalin treated speci-
mens.
Aftermore than 6 years the patient is without any signs ofrecurrences, and maintains
his weight in spite ofexocrine pancreatic insufficiency with mild diarrhoea.
DISCUSSION
Reviewing the literature, we found four putative long-lt_e4rm survivors after resection for
ductal carcinomas in the body or tail of the pancreas
The first recorded long-time survival after resection ofa ductal carcinoma in thebody
of the pancreas was published in a Russian journal in 1922 and abstracted in English
in 1923 A 30-year-oldwoman had had upperabdominal pain formany years. Physical
examination revealed a hard, mobile tumor in the left hypochondrium At laparotomy
in 1913, a hard, nodular, mobile tumor, the size of two fists was localized behind the
stomach. It was removed by a subtotal pancreatectomy leaving a by 3 cm piece ofthe
head of the pancreas. Microscopy showed a "cylindrical-cell carcinoma". The patient
developed a mild pancreatic insufficiency but no diabetes. She was doing well up to
1918when a hard tumor at the size ofa peawas discovered in the left clavicle. Radiation
therapy was given. The patient was doing fairly well up to 1922, when she was lost for
follow-up.
The second case was operatedupon in 19272. The patient was a slim 54-year-old male
who had had fatigue for two months and had noticed a lump in the upper left abdomen.RESECTION OF PANCREATIC CARCINOMA 53
Physical examination revealed a prominent visible tumor in the left hypochondrium.
At laparotomy a tumor the size of one and a half fist was found in the lesser omental
sac. A subtotal pancreatectomy was performed, leaving behind a minute fragment of
the pancreas in the duodenal concavity. It was necessary to resect the splenic artery and
a part of the splenic vein as well as a part of the portal vein. Microscopy showed
"columnar cell carcinoma". The patient did not develop diabetes, and almost 7 years
after the operation he was in an excellent state of health.
Figure 1 Histologic appearance of the pancreatic cancer showing an infiltrating ductal carcinoma
(H&E x 120).
The third casewas from a series ofcancer ofthe body and tail ofthe pancreas reported
in 19713. A woman was operated upon for a suspected pancreatic pseudocyst, but a
small tumor was found in the distal pancreas. It was removed by a simple wedge
resection. Microscopy showed adenocarcinoma. She was doing well 15 years later.
The fourth case appears from a table in a paper summarizing the results of surgical
treatment of pancreatic cancer in 57 institutions in Japan. The patient is the one who
survived more than 5 years, but less than 10 years, among 66 patients who survived
resections of cancer in the body or tail of the pancreas.
It is beyond any doubt that these four reported cases had cancer of the body or tail
ofthe pancreas. However, because of the huge size ofthe two first cases they may have
been cystadenocarcinomas which have a better prognosis than true ductal cancer.
Further, endocrine and germinative tumors in the pancreas have good prognosis.
Accordingly an exact histopathological diagnosis is mandatory.54 P. BILLESBLLE ET AL.
Our patient, the 5th reported 5-year-survivor in three quarters ofa century, showed
two distinctive features. There was two instances of late metastasis (abdominal wall
and stomach) amenable to surgery and primary cancers in the prostate and breast
supporting the theory, that pancreaticcancermay be a sex-hormone dependent tumor5.
The hormone dependency was not known to us at the time of surgery, and delayed
hormone receptor analysis was not possible.
Of patients with ductal carcinomas of the pancreatic body and tail, only a few seem
to benefit from pancreatic resection, as most patients die within one year.
Only by detailed reporting on long-term survivors, it will be possible to decide ifthey
possess unique characteristics.
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INVITED COMMENTARY
The authors have made a contribution in demonstrating the incredible infrequency of
cure of this specific lesion. Surgeons, however, must not abandon attempts for cure.
Whereas this commentator has not achieved cure of a ductal cancer of the tail of the
pancreas, he has achieved a four year survivor plus longer term survivors of patients
with carcinoid and patients with mucinous cystadenocarcinoma ofthe tail. Histological
subclassification ofpancreatic (exocrine) cancers may give further prognostic informa-
tion. Anatomic localization ofsome ofthe cancers which present on the cephalic aspect
of the pancreas, along the portal vein, may be indefinite as to whether they originate
in the "head or body" but it is obvious that the prognosis is bad.
Although the outlook for immediate progress is not bright, the combination of
ERCP and serum Ca19-9 determination may provide additional survivors. Perhaps
determination of Ca19-9 titer in pancreatic juice, collected via E.R.P. cannulation,
might give helpful information.
The tumor and the patient were unusual as reflected in the long term survival and
the multiplicity of tumors. In the commentator’s experience, the occasional long term
survivor ofpancreatic cancer is usually female in spite ofthe fact that pancreatic cancer
is more frequent in the male. The patient being reported had carcinomas of the breast
and prostate, each obviously sex related in occurrence and in response to hormone
therapy. Although estrogen has been shown to be involved in pancreatic metabolism,RESECTION OF PANCREATIC CARCINOMA 55
sex hormones have not been clearly implicated in either the causation or therapy of
pancreatic ductal carcinoma. We routinely assay pancreatic cancers for estrogen and
progesterone receptors but the findings are usually negative. Numerous studies, espe-
cially in Europe, are underway to explore the hormonal parameters of pancreatic
cancer. Although potentially quite important, these studies to date do not yet provide
effective clinical application.
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INVITED COMMENTARY
This is indeed a remarkable case. The relatively long history (halfa year), the pre-oper-
ative angiographic evidence of splanchnic infiltration, the considerable size of the
tumor (11 x 10 7cm) and its infiltration oftheretro-peritoneum- allofthese findings
really weighed the odds against resectability, let alone long-term survival.
And yet this patient did survive not only an extensive resection ofthe primary tumor
(including transverse colon and spleen), but also two further resections of metastases
4 and 10 months later.
And then this male patient went on to develop mammary and prostatic cancers, both
ofwhich were also cured by surgery.
Returning to this adenocarcinoma of the body and tail of the pancreas, the authors
have rightly stressed the importance of verification of the histology. As we all know:
"Even ifyou admire your pathologist as much as I do mine you cannot give him your
full trust on pancreatic histology" (Harbrecht 1974). If this is true- and I think it is-
I would suggest, that the histological slides of this case be sent to an independent
pathologist for a second opinion. And then it might be possible to examine the
preparations by immunohistochemical studies, just to rule out the possibility of some
form of malignant apudoma.
The authors’ allusion to sex-hormone dependence of pancreatic tumors is pertinent
to this case, but it lacks practical significance for this patient. So far none ofthe studies
using tamoxifen have shown any significant effect on long-time survival (Greenway
1988). It is remarkable (and commendable) that the authors apparently resisted the
temptation of treating this patient with adjuvant chemotherapy. It is worth comment-
ing that this remarkable patient was cured of carcinoma of the pancreas by surgery
alone.
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